AKT activation has been demonstrated in malignant pleural mesothelioma specimens and PI3K/mTOR inhibitors significantly suppressed malignant pleural mesothelioma cell growth [63]. This evidence concerns the gene AKT1 and malignant pleural mesothelioma.